Miao et al., 2018 - Google Patents
Stable and non-toxic ultrasmall gadolinium oxide nanoparticle colloids (coating material= polyacrylic acid) as high-performance T 1 magnetic resonance imaging …Miao et al., 2018
View HTML- Document ID
- 3300917858926692594
- Author
- Miao X
- Ho S
- Tegafaw T
- Cha H
- Chang Y
- Oh I
- Yaseen A
- Marasini S
- Ghazanfari A
- Yue H
- Chae K
- Lee G
- Publication year
- Publication venue
- RSC advances
External Links
Snippet
For use as positive (T1) magnetic resonance imaging contrast agents (MRI-CAs), gadolinium oxide (Gd2O3) nanoparticle colloids (ie nanoparticles coated with hydrophilic ligands) should be stable, non-toxic, and ultrasmall in particle diameter for renal excretion. In …
- 239000002105 nanoparticle 0 title abstract description 91
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1833—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Miao et al. | Stable and non-toxic ultrasmall gadolinium oxide nanoparticle colloids (coating material= polyacrylic acid) as high-performance T 1 magnetic resonance imaging contrast agents | |
| Khalkhali et al. | The impact of polymer coatings on magnetite nanoparticles performance as MRI contrast agents: a comparative study | |
| Wu et al. | The behavior after intravenous injection in mice of multiwalled carbon nanotube/Fe3O4 hybrid MRI contrast agents | |
| Huang et al. | Tunable T 1 and T 2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control | |
| Hu et al. | Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrastT1-andT2-weighted magnetic resonance imaging | |
| Amiri et al. | Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles | |
| CN103826840B (en) | Magnetic graphene-like nanoparticles or graphitic nano-or microparticles and method of production and uses thereof | |
| Cho et al. | Gadolinium oxide nanoplates with high longitudinal relaxivity for magnetic resonance imaging | |
| Yan et al. | Self-assembled magnetic fluorescent polymeric micelles for magnetic resonance and optical imaging | |
| Ma et al. | Biocompatible composite nanoparticles with large longitudinal relaxivity for targeted imaging and early diagnosis of cancer | |
| Jin et al. | An ultrasmall and metabolizable PEGylated NaGdF 4: Dy nanoprobe for high-performance T 1/T 2-weighted MR and CT multimodal imaging | |
| Yang et al. | Monodisperse water-soluble Fe–Ni nanoparticles for magnetic resonance imaging | |
| Ramasamy et al. | Molecular encapsulator on the surface of magnetic nanoparticles. Controlled drug release from calcium Ferrite/Cyclodextrin–tethered polymer hybrid | |
| Zhou et al. | Functionalized graphene oxide/Fe3O4 hybrids for cellular magnetic resonance imaging and fluorescence labeling | |
| Pour et al. | Carboxymethyl cellulose (CMC)-loaded Co-Cu doped manganese ferrite nanorods as a new dual-modal simultaneous contrast agent for magnetic resonance imaging and nanocarrier for drug delivery system | |
| Kim et al. | Mesoporous silica-coated luminescent Eu 3+ doped GdVO 4 nanoparticles for multimodal imaging and drug delivery | |
| Lee et al. | Development of a controlled-release drug delivery system by encapsulating oxaliplatin into SPIO/MWNT nanoparticles for effective colon cancer therapy and magnetic resonance imaging | |
| Yue et al. | Carbon-coated ultrasmall gadolinium oxide (Gd2O3@ C) nanoparticles: Application to magnetic resonance imaging and fluorescence properties | |
| Babić-Stojić et al. | Gd2O3 nanoparticles stabilized by hydrothermally modified dextrose for positive contrast magnetic resonance imaging | |
| Miao et al. | Ultrasmall Gd2O3 nanoparticles surface-coated by polyacrylic acid (PAA) and their PAA-size dependent relaxometric properties | |
| Amiri et al. | Superparamagnetic colloidal nanocrystal clusters coated with polyethylene glycol fumarate: a possible novel theranostic agent | |
| Babić-Stojić et al. | Ultrasmall iron oxide nanoparticles: Magnetic and NMR relaxometric properties | |
| Hu et al. | Water-soluble and biocompatible MnO@ PVP nanoparticles for MR imaging in vitro and in vivo | |
| Guldris et al. | Influence of the separation procedure on the properties of magnetic nanoparticles: Gaining in vitro stability and T1–T2 magnetic resonance imaging performance | |
| Yue et al. | Ultrasmall europium, gadolinium, and dysprosium oxide nanoparticles: Polyol synthesis, properties, and biomedical imaging applications |